Lampren 100 mg Capsule

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

clofaziminum

MAH:

Novartis Pharma Schweiz AG

ATC_code:

J04BA01

INN:

clofaziminum

pharmaceutical_form:

Capsule

composition:

clofaziminum 100 mg, rapae oleum raffinatum, lecithinum, sojae oleum partim hydrogenatum 9.333 mg, sojae oleum hydrogenatum 2.333 mg, cera flava, propylenglycolum, E 321, acidum citricum, Kapselhülle: gelatina, glycerolum (85 per centum), E 172 (rubrum), E 172 (nigrum), E 215 550 µg, ethylvanillinum, propylis parahydroxybenzoas natricus 280 µg, 4-methoxyacetophenonum, aqua purificata, Drucktinte: lacca, E 171, propylenglycolum, pro capsula.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

La lebbra

authorization_status:

zugelassen

authorization_date:

1970-01-01